Literature DB >> 15935233

A history of major depressive disorder and the response to stress.

Mark A Ilgen1, Kent E Hutchison.   

Abstract

BACKGROUND: The occurrence of Major Depressive Disorder (MDD) has been linked to an increased vulnerability to stress. However, the specific behavioral and affective aspects that may underlie this vulnerability to stress have not been well studied.
METHODS: This study examined sensitivity to a stress manipulation in 62 participants, 30 with and 32 without a previous episode of MDD. Comparisons were made between those with a history of depression and those without, randomized to either the high or low stress conditions on self-report measures of affect and behavior measures of performance.
RESULTS: A significant interaction was found between depression history and level of stress on measures of self-report tension and behavioral performance on the experimental task. Specifically, those with a history of MDD in the high stress condition reported significantly more tension than other participants. Additionally, participants in the high stress condition without a history of MDD responded to uncontrollable stress by responding at a significantly higher rate on the task while those individuals with a history of MDD responded to uncontrollable stress by maintaining a relatively low level of responding. No differences in self-report depressed affect were found. LIMITATIONS: The study utilized a laboratory stressor in a sample composed primarily of college students.
CONCLUSIONS: A history of MDD appears to be associated with an increased sensitivity to uncontrollable stress. This vulnerability may manifest itself in the subjective state of individuals (i.e., tension) or in their behavioral responses to stress.

Entities:  

Mesh:

Year:  2005        PMID: 15935233     DOI: 10.1016/j.jad.2005.01.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Association between Na⁺,K⁺-ATPase activity and the vulnerability/resilience to mood disorders induced by early life experience.

Authors:  Patrícia Pelufo Silveira; André Krumel Portella; Carla da Silva Benetti; Alexandra Ioppi Zugno; Emilene Barros da Silva Scherer; Cristiane Bastos Mattos; Angela T S Wyse; Aldo Bolten Lucion; Carla Dalmaz
Journal:  Neurochem Res       Date:  2011-06-22       Impact factor: 3.996

Review 2.  [Stress, mental disorders and coronary heart disease].

Authors:  F Lederbogen; A Ströhle
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

3.  Lifetime history of depression, type 2 diabetes, and endothelial reactivity to acute stress in postmenopausal women.

Authors:  Julie A Wagner; Howard Tennen; Patrick H Finan; William B White; Matthew M Burg; Nimrta Ghuman
Journal:  Int J Behav Med       Date:  2012-12

4.  Psychopharmacology of maternal separation anxiety in vervet monkeys.

Authors:  Lelanie Marais; Willie Daniels; Linda Brand; Francois Viljoen; Charmaine Hugo; Dan J Stein
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

5.  The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Authors:  Joshua A Azevedo; Bradley S Carter; Fan Meng; David L Turner; Manhong Dai; Alan F Schatzberg; Jack D Barchas; Edward G Jones; William E Bunney; Richard M Myers; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  J Psychiatr Res       Date:  2016-07-18       Impact factor: 4.791

6.  Cognitive impairments, emotion, stress, and language in schizophrenia.

Authors:  James P Seghers; Nancy M Docherty
Journal:  Psychiatry Res       Date:  2009-10-30       Impact factor: 3.222

7.  A population-based study on ways of dealing with daily stress: comparisons among individuals with mental disorders, with long-term general medical conditions and healthy people.

Authors:  JianLi Wang; Leslie-Anne Keown; Scott B Patten; Jeanne A Williams; Shawn R Currie; Cynthia A Beck; Colleen J Maxwell; Nady A El-Guebaly
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-27       Impact factor: 4.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.